DentistryPharmacokineticsPharmacologyClinical PharmacologyEpilepsySalivary DiagnosticsAnalytical ValidationPoint-of-care Salivary TestingSalivary BiomarkersCarbamazepine PharmacologyFree Drug Concentration MeasurementFree Drug Concentration MonitoringHigh-performance Liquid ChromatographyObjective Salivary TestingSaliva BiosensingSalivary Drug MonitoringTherapeutic Drug Monitoring Biomarkers
Therapeutic drug monitoring (TDM) of carbamazepine (CBZ) in saliva is an attractive alternative, because its collection is painless, non-invasive and simpler than drawing blood. Salivary drug levels, also closely reflect the free drug concentration. The aim of the study was to evaluate the suitability of saliva in routine TDM of CBZ in adult epileptic patients. Blood and saliva samples were taken simultaneously at 0 hours and 24 hours of CBZ dosing from 31 epileptic patients, receiving CBZ monotherapy for three or more months. Levels of CBZ in both these fluids were measured by high performance liquid chromatography. Strong and highly significant correlation was found between serum and salivary CBZ concentration (r = 0.659, p<0.001). Estimation of CBZ level in saliva is thus a practicable, valid and convenient method of TDM in epileptic patients.
6